Ascentage Pharma Group International (AAPG) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q4'21 | Q2'21 | Q4'20 | Q2'20 | Q4'19 | Q2'19 | Q4'18 | Q2'18 | Q4'17 | Q2'17 |
|---|
| Sales/Revenue | 334.13M | 233.7M | 156.9M | 823.75M | 79.28M | 142.7M | 104.86M | 104.86M | 14.95M | 12.96M | 6.22M | 6.22M | 7.26M | 7.26M | 5.11M | 1.7M | 6.05M | 275.25K |
| Revenue Growth % | 112.95% | -71.63% | 97.9% | 477.26% | -24.39% | 36.09% | 601.61% | 708.76% | 140.08% | 108.27% | -14.21% | -14.21% | 42.03% | 327.36% | -15.59% | 516.9% | - | - |
| Cost of Goods Sold | 68.69M | 21.65M | 14.03M | 15.06M | 12.39M | 18.15M | 11M | 11M | 739K | 2.59M | 983K | 983K | 1.05M | 1.05M | -504.49K | 504.49K | -276.84K | 276.84K |
| COGS % of Revenue | 20.56% | 9.26% | 8.94% | 1.83% | 15.63% | 12.72% | 10.49% | 10.49% | 4.94% | 19.97% | 15.79% | 15.79% | 14.44% | 14.44% | -9.87% | 29.71% | -4.57% | 100.58% |
| Gross Profit | 265.45M | 212.05M | 142.88M | 808.69M | 66.89M | 124.55M | 93.86M | 93.86M | 14.21M | 10.38M | 5.24M | 5.24M | 6.21M | 6.21M | 5.11M | -363.27K | 6.33M | -1.6K |
| Gross Margin % | 79.44% | 90.74% | 91.06% | 98.17% | 84.37% | 87.28% | 89.51% | 89.51% | 95.06% | 80.03% | 84.21% | 84.21% | 85.56% | 85.56% | 100% | -21.39% | 104.57% | -0.58% |
| Gross Profit Growth % | 85.79% | -73.78% | 113.59% | 549.3% | -28.73% | 32.7% | 560.68% | 804.55% | 171% | 97.94% | -15.57% | -15.57% | 21.52% | 1809.07% | -19.28% | -22661.09% | - | - |
| Operating Expenses | 906.3M | 766.03M | 709.66M | 620.7M | 598.96M | 465.12M | 518.76M | 518.76M | 447.21M | 447.21M | 337.21M | 337.21M | 297.55M | 297.55M | 215.65M | 6.84M | 134.53M | 2.47M |
| OpEx % of Revenue | 271.24% | 327.79% | 452.29% | 75.35% | 755.46% | 325.94% | 494.74% | 494.74% | 2992.36% | 3449.35% | 5417.07% | 5417.07% | 4100.48% | 4100.48% | 4220.88% | 402.8% | 2222.55% | 897.47% |
| Selling, General & Admin | 318.79M | 237.47M | 206.5M | 176.63M | 201.8M | 174.66M | 164.01M | 164.01M | 95.63M | 95.63M | 32.03M | 32.03M | 49.43M | 49.43M | 42.53M | 1.58M | 12.62M | 787.26K |
| SG&A % of Revenue | 95.41% | 101.61% | 131.61% | 21.44% | 254.53% | 122.4% | 156.41% | 156.41% | 639.88% | 737.61% | 514.52% | 514.52% | 681.13% | 681.13% | 832.53% | 92.89% | 208.46% | 286.02% |
| Research & Development | 587.52M | 528.56M | 503.17M | 444.08M | 397.16M | 309.81M | 371.55M | 371.55M | 383.25M | 383.25M | 282.29M | 282.29M | 231.94M | 231.94M | 244.3M | 5.26M | 117.13M | 1.68M |
| R&D % of Revenue | 175.83% | 226.17% | 320.68% | 53.91% | 500.93% | 217.11% | 354.35% | 354.35% | 2564.37% | 2956% | 4534.71% | 4534.71% | 3196.33% | 3196.33% | 4781.81% | 309.9% | 1935.19% | 611.45% |
| Other Operating Expenses | 0 | 0 | 0 | -2K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 0 | 1000K | 0 |
| Operating Income | -640.85M | -553.98M | -566.79M | 187.98M | -532.07M | -340.57M | -424.9M | -424.9M | -434.92M | -434.92M | -331.97M | -331.97M | -291.34M | -291.34M | -338.24M | -7.2M | -128.2M | -2.47M |
| Operating Margin % | -191.8% | -237.05% | -361.23% | 22.82% | -671.09% | -238.66% | -405.23% | -405.23% | -2910.12% | -3354.55% | -5332.86% | -5332.86% | -4014.92% | -4014.92% | -6620.49% | -424.19% | -2117.98% | -898.05% |
| Operating Income Growth % | -13.07% | -394.7% | -6.53% | 155.2% | -25.22% | 19.85% | 2.3% | 2.3% | -31.01% | -31.01% | -13.95% | -13.95% | 13.87% | -3944.88% | -163.85% | -191.39% | - | - |
| EBITDA | -598.95M | -514.02M | -528.45M | 229.59M | -492.67M | -286.77M | -420.34M | -420.34M | -432.72M | -432.72M | -329.98M | -329.98M | -289.43M | -289.43M | -319.56M | -6.7M | -115.97M | -2.19M |
| EBITDA Margin % | -179.26% | -219.95% | -336.8% | 27.87% | -621.4% | -200.96% | -400.88% | -400.88% | -2895.43% | -3337.61% | -5300.95% | -5300.95% | -3988.56% | -3988.56% | -6254.91% | -394.48% | -1916.02% | -797.47% |
| EBITDA Growth % | -13.34% | -323.89% | -7.26% | 180.06% | -17.21% | 31.78% | 2.86% | 2.86% | -31.13% | -31.13% | -14.01% | -14.01% | 9.43% | -4220.96% | -175.55% | -205.16% | - | - |
| D&A (Non-Cash Add-back) | 41.9M | 39.97M | 38.33M | 41.6M | 39.4M | 53.8M | 4.56M | 4.56M | 2.2M | 2.2M | 1.99M | 1.99M | 1.91M | 1.91M | 18.68M | 504.49K | 12.22M | 276.84K |
| EBIT | -640.85M | -553.98M | -566.79M | 187.98M | -532.07M | -304.74M | -417.19M | -417.19M | -407.76M | -407.76M | -334.6M | -334.6M | -739.02M | -739.02M | -211.24M | 314.98K | -60.56M | -1.62M |
| Net Interest Income | 23.99M | 3.61M | 1.43M | -28.04M | -20.28M | -43.37M | -21.53M | -21.53M | -4.81M | -4.81M | -518.5K | -518.5K | 4.32M | 4.32M | -27.47M | -2.39M | -55.66M | -1.98M |
| Interest Income | 49.78M | 3.61M | 1.43M | 1.3M | 3.64M | 32.41M | 4.86M | 4.86M | 3.55M | 3.55M | 2.61M | 2.61M | 6.45M | 6.45M | 7.06M | 0 | 304K | 0 |
| Interest Expense | 25.79M | 0 | 0 | 28.04M | 20.28M | 75.78M | 26.39M | 26.39M | 8.37M | 8.37M | 3.13M | 3.13M | 2.14M | 2.14M | 34.53M | 2.39M | 55.96M | 1.98M |
| Other Income/Expense | 2.14M | -31.33M | 8.64M | -25.09M | -1.19M | -59.04M | -18.68M | -18.68M | 18.79M | 7.31M | -5.75M | -5.75M | -449.82M | -449.82M | -20.13M | 0 | 11.68M | -1.13M |
| Pretax Income | -638.72M | -585.31M | -558.15M | 162.9M | -533.26M | -399.6M | -443.59M | -443.59M | -416.12M | -374.38M | -337.72M | -337.72M | -741.16M | -741.16M | -358.37M | -2.07M | -116.52M | -3.6M |
| Pretax Margin % | -191.16% | -250.46% | -355.73% | 19.77% | -672.59% | -280.03% | -423.05% | -423.05% | -2784.37% | -2887.59% | -5425.29% | -5425.29% | -10213.71% | -10213.71% | -7014.44% | -122.09% | -1925.04% | -1307.28% |
| Income Tax | 1.4M | 5.51M | 10.36M | 69K | -9.9M | 2.75M | -2.12M | -2.12M | -24.91M | -24.91M | 1.08M | 1.08M | -801K | -801K | 801K | -63.06K | -1.54M | -58.21K |
| Effective Tax Rate % | -0.22% | -0.94% | -1.86% | 0.04% | 1.86% | -0.69% | 0.48% | 0.48% | 5.99% | 6.65% | -0.32% | -0.32% | 0.11% | 0.11% | -0.22% | 3.04% | 1.32% | 1.62% |
| Net Income | -639.96M | -590.77M | -568.43M | 163M | -523.29M | -402.35M | -441.46M | -441.46M | -391.21M | -391.21M | -338.8M | -338.8M | -740.36M | -740.36M | -343.3M | -2.01M | -114.97M | -3.54M |
| Net Margin % | -191.53% | -252.79% | -362.28% | 19.79% | -660.01% | -281.96% | -421.02% | -421.02% | -2617.68% | -3017.45% | -5442.62% | -5442.62% | -10202.67% | -10202.67% | -6719.45% | -118.38% | -1899.53% | -1286.13% |
| Net Income Growth % | -12.58% | -462.43% | -8.63% | 140.51% | -18.53% | 8.86% | -12.84% | -12.84% | -15.47% | -15.47% | 54.24% | 54.24% | -115.66% | -36732.23% | -198.59% | 43.22% | - | - |
| Net Income (Continuing) | -640.12M | -590.82M | -568.51M | 162.83M | -523.36M | -402.35M | -441.46M | -441.46M | -391.21M | -391.21M | -338.8M | -338.8M | -740.36M | -740.36M | -343.3M | -2.01M | -114.97M | -3.54M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 9.76M | 9.91M | 9.97M | 10.04M | 10.21M | 10.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -6.92 | -6.92 | -7.28 | 2.20 | -7.20 | -45.28 | -26.80 | -26.80 | -24.56 | -24.56 | -25.12 | -25.12 | -56.00 | -56.00 | -26.52 | -0.16 | -8.88 | -0.29 |
| EPS Growth % | 4.95% | -414.55% | -1.11% | 104.86% | 73.13% | -68.96% | -9.12% | -9.12% | 2.23% | 2.23% | 55.14% | 55.14% | -111.16% | -34900% | -198.65% | 44.83% | - | - |
| EPS (Basic) | -6.92 | -6.92 | -7.28 | 2.24 | -7.20 | -45.28 | -26.80 | -26.80 | -24.56 | -24.56 | -25.12 | -25.12 | -56.00 | -56.00 | -26.52 | -0.16 | -8.88 | -0.29 |
| Diluted Shares Outstanding | 92.6M | 85.4M | 78.09M | 74.01M | 72.51M | 17.64M | 16.48M | 16.48M | 15.91M | 15.91M | 13.49M | 13.49M | 13.22M | 13.22M | 12.94M | 12.29M | 12.94M | 12.29M |
| Basic Shares Outstanding | 92.6M | 85.37M | 78.09M | 74.09M | 72.51M | 17.64M | 16.48M | 16.48M | 15.91M | 15.91M | 13.49M | 13.49M | 13.22M | 13.22M | 12.94M | 12.29M | 12.94M | 12.29M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |